SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 152 filers reported holding SERES THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $864,111 | -55.0% | 363,072 | -9.3% | 0.00% | – |
| Q2 2023 | $1,918,266 | -48.6% | 400,473 | -39.1% | 0.00% | -100.0% |
| Q1 2023 | $3,728,553 | +728.9% | 657,593 | +718.6% | 0.00% | – |
| Q4 2022 | $449,842 | -37.3% | 80,329 | -28.1% | 0.00% | – |
| Q3 2022 | $718,000 | +0.8% | 111,788 | -46.1% | 0.00% | – |
| Q2 2022 | $712,000 | -67.1% | 207,491 | -31.7% | 0.00% | – |
| Q1 2022 | $2,162,000 | -48.5% | 303,677 | -39.8% | 0.00% | -100.0% |
| Q4 2021 | $4,200,000 | +179.6% | 504,232 | +133.8% | 0.00% | – |
| Q3 2021 | $1,502,000 | -84.1% | 215,706 | -45.4% | 0.00% | -100.0% |
| Q2 2021 | $9,418,000 | +6.7% | 394,863 | -7.9% | 0.00% | -50.0% |
| Q1 2021 | $8,830,000 | +7.1% | 428,802 | +27.5% | 0.00% | 0.0% |
| Q4 2020 | $8,242,000 | +156.0% | 336,371 | +195.8% | 0.00% | +100.0% |
| Q3 2020 | $3,219,000 | +383.3% | 113,718 | -18.7% | 0.00% | – |
| Q2 2020 | $666,000 | +313.7% | 139,845 | +209.2% | 0.00% | – |
| Q1 2020 | $161,000 | -4.2% | 45,228 | -7.2% | 0.00% | – |
| Q4 2019 | $168,000 | +133.3% | 48,748 | +172.4% | 0.00% | – |
| Q3 2019 | $72,000 | -66.0% | 17,897 | -72.7% | 0.00% | – |
| Q2 2019 | $212,000 | +94.5% | 65,639 | +313.9% | 0.00% | – |
| Q1 2019 | $109,000 | -45.5% | 15,858 | -64.3% | 0.00% | – |
| Q4 2018 | $200,000 | -16.3% | 44,429 | +41.5% | 0.00% | – |
| Q3 2018 | $239,000 | +30.6% | 31,400 | +48.0% | 0.00% | – |
| Q2 2018 | $183,000 | -81.8% | 21,217 | -84.5% | 0.00% | -100.0% |
| Q1 2018 | $1,005,000 | -28.0% | 136,924 | -0.5% | 0.00% | 0.0% |
| Q4 2017 | $1,396,000 | +206.8% | 137,664 | +242.3% | 0.00% | – |
| Q2 2017 | $455,000 | +95.3% | 40,212 | +94.6% | 0.00% | – |
| Q1 2017 | $233,000 | +99.1% | 20,662 | +74.8% | 0.00% | – |
| Q4 2016 | $117,000 | -92.3% | 11,821 | -90.4% | 0.00% | -100.0% |
| Q3 2016 | $1,513,000 | -81.1% | 123,137 | -36.3% | 0.00% | -85.7% |
| Q2 2015 | $8,019,000 | – | 193,226 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |